Julie Papanek Grant's Net Worth
$262 Million
Who is Julie Papanek Grant?
Julie Papanek Grant has an estimated net worth of $262 Million. This is based on reported shares across multiple companies, which include Day One Biopharmaceuticals, Inc., and Protagonist Therapeutics, Inc.
SEC CIK
Julie Papanek Grant's CIK is 0001673237
Past Insider Trading and Trends
2021 was Julie Papanek Grant's most active year for acquiring shares with 5 total transactions. Julie Papanek Grant's most active month to acquire stocks was the month of May. 2022 was Julie Papanek Grant's most active year for disposing of shares, totalling 33 transactions. Julie Papanek Grant's most active month to dispose stocks was the month of August. 2016 saw Julie Papanek Grant paying a total of $6,999,996.00 for 2,477,255 shares, this is the most they've acquired in one year. In 2022 Julie Papanek Grant cashed out on 2,761,144 shares for a total of $25,464,573.03, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Day One Biopharmaceuticals, Inc. (DAWN) Snapshot price: $15.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -7.04% | -25.00K |
$18.61 | -$465,302.50 | 330K |
Scheduled
|
Mar 1
| ||
Form 4
| -6.58% | -25.00K |
$21.23 | -$530,794.33 | 355K |
Scheduled
|
Feb 1
| ||
Form 4
| -6.17% | -25.00K |
$20.65 | -$516,147.12 | 380K |
Scheduled
|
Jan 3
| ||
Form 4
| -1.06% | -4.36K |
$22.08 | -$96,210.26 | 405K |
Scheduled
|
Dec 8
| ||
Form 4
| -2.38% | -10.00K |
$21.65 | -$216,480.39 | 409.36K |
Scheduled
|
Dec 1 - Dec 2
| ||
Form 4
| -2.33% | -10.00K |
$20.03 | -$200,277.50 | 419.36K |
Scheduled
|
Nov 1 - Nov 2
| ||
Form 4
| -2.28% | -10.00K |
$20.03 | -$200,315.00 | 429.36K |
Scheduled
|
Oct 3 - Oct 4
| ||
Form 4
| -23.28% | -2.11M |
$18.55 |
—
| 6.96M |
Sep 21
| |||
Form 4
| -3.62% | -340.70K |
$20.44 | -$6,963,115.78 | 9.08M |
Sep 16 - Sep 20
| |||
Form 4
| -2.54% | -245.04K |
$23.76 | -$5,823,084.06 | 9.42M |
Sep 13 - Sep 15
| |||
Form 4
| -1.13% | -5.00K |
$23.82 | -$119,107.50 | 439.36K |
Scheduled
|
Sep 2
| ||
Form 4
| -1.11% | -5.00K |
$23.27 | -$116,358.38 | 444.36K |
Scheduled
|
Sep 1
| ||
Form 4
| -2.18% | -10.00K |
$20.00 | -$200,004.00 | 449.36K |
Scheduled
|
Aug 4 - Aug 5
| ||
Form 4
| -0.56% | -2.60K |
$20.00 | -$52,001.04 | 459.36K |
Scheduled
|
Jul 18
| ||
Form 4/A
| -0.39% | -1.80K |
$20.00 | -$36,000.00 | 463.2K |
Scheduled
|
Jul 1 - Jul 5
| ||
Form 4
| -0.27% | -1.24K |
$20.00 | -$24,840.00 | 461.96K |
Scheduled
|
Jul 8
| ||
Form 4
| -0.39% | -1.80K |
$20.00 | -$36,000.00 | 463.2K |
Scheduled
|
Jul 1 - Jul 5
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
| +230.75% | 7.49M |
$16.00 |
—
| 10.74M |
Feb 1 - Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Protagonist Therapeutics, Inc (PTGX) Snapshot price: $25.76
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 13
| |||
Form 4
|
∞
| 2.45M |
$12.00 |
—
| 2.45M |
Aug 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||